Managing localized prostate cancer in the era of prostate‐specific antigen screening

A predictive tool has been developed and validated that identifies patients with low‐risk cancer on biopsy who are at risk for upgrading at surgery. This tool could help increase acceptance and safety of active surveillance and lower the number of men overtreated for low‐risk prostate cancer.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2013-11, Vol.119 (22), p.3906-3909
1. Verfasser:	Brooks, James D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Early Detection of Cancer - methods Humans Kallikreins - blood Male Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A predictive tool has been developed and validated that identifies patients with low‐risk cancer on biopsy who are at risk for upgrading at surgery. This tool could help increase acceptance and safety of active surveillance and lower the number of men overtreated for low‐risk prostate cancer.
ISSN:	0008-543X 1097-0142
DOI:	10.1002/cncr.28301